NCT04544007
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04544007
Title A Phase II Trial of Poly-ICLC for Low-Grade Gliomas (NF111)
Acronym NF111
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
The University of Alabama at Birmingham (Site 700) Birmingham Alabama 35294 United States Details
Children's Hospital of Los Angeles Los Angeles California 90027 United States Details
Children's National Medical Center (Site 775) Washington D.C. District of Columbia 20010 United States Details
Children's Healthcare of Atlanta Atlanta Georgia 30342 United States Details
Children's Lurie Hospital Chicago Illinois 60611 United States Details
Lurie Children's Hospital of Chicago (Site 350) Chicago Illinois 60611 United States Details
University of Chicago (Site 850) Chicago Illinois 60637 United States Details
Washington University - St. Louis (Site 900) St Louis Missouri 63110 United States Details
New York University Medical Center (Site 200) New York New York 10016 United States Details
Cincinnati Children's Hospital Medical Center (Site 800) Cincinnati Ohio 45229-3039 United States Details
Children's Hospital of Philadelphia (Site 750) Philadelphia Pennsylvania 19096 United States Details
Childrens Medical Center - Univ. of Texas SW (Site 917) Dallas Texas 75235 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field